Today, October 19, 2024, all of us at Lumia Health™ (formerly STAT Health) are excited to launch our 30-Day Crowdfunding Campaign and open pre-orders for Lumia™ device. The in-ear wearable device is the world's first consumer device that can track drops in blood flow to your head.
The latest scientific research on brain blood flow in orthostatic intolerance shows that in individuals with a wide variety of Orthostatic Syndromes -- including POTS, Long Covid, ME/CFS, Orthostatic Hypotension, and more -- there is a significant drop in Cerebral Blood Flow (CBF) during upright body postures.
The Lumia™ device, with its in-ear placement, is capable of reading rich biometric signals from the External Carotid Artery in the left ear. The proprietary Lumia Flow Index™ has been shown to correlate well with CBF measurement in laboratory settings.
With their new ear device, for the first time ever, individuals with autonomic nervous system disorders like Postural Orthostatic Tachycardia Syndrome will be able to better understand how their lifestyle modifications, body positions, environmental conditions, and other factors may be influencing blood flow.
The Lumia™ wearable device is not a medical device, and should not be used to diagnose or treat any condition. It is available for wellness purposes only, to help you self-manage your symptoms.
There will be 500 "Beta Customer" specials and as well as "Early Bird" specials.
